Free Trial

Omeros (OMER) Stock Price, News & Analysis

Omeros logo
$8.10 -1.73 (-17.60%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$8.11 +0.01 (+0.11%)
As of 10/17/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Omeros Stock (NASDAQ:OMER)

Advanced

Key Stats

Today's Range
$7.96
$9.66
50-Day Range
$4.03
$10.42
52-Week Range
$2.95
$13.60
Volume
7.44 million shs
Average Volume
8.02 million shs
Market Capitalization
$551.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.50
Consensus Rating
Moderate Buy

Company Overview

Omeros Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
86th Percentile Overall Score

OMER MarketRank™: 

Omeros scored higher than 86% of companies evaluated by MarketBeat, and ranked 131st out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Omeros has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Omeros has a consensus price target of $27.50, representing about 239.5% upside from its current price of $8.10.

  • Amount of Analyst Coverage

    Omeros has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Omeros' stock forecast and price target.
  • Earnings Growth

    Earnings for Omeros are expected to grow in the coming year, from ($3.09) to ($1.73) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Omeros is -3.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Omeros is -3.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Omeros' valuation and earnings.
  • Percentage of Shares Shorted

    18.60% of the outstanding shares of Omeros have been sold short.
  • Short Interest Ratio / Days to Cover

    Omeros has a short interest ratio ("days to cover") of 11.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Omeros has recently decreased by 6.22%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Omeros does not currently pay a dividend.

  • Dividend Growth

    Omeros does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    18.60% of the outstanding shares of Omeros have been sold short.
  • Short Interest Ratio / Days to Cover

    Omeros has a short interest ratio ("days to cover") of 11.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Omeros has recently decreased by 6.22%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Omeros has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 40 news articles for Omeros this week, compared to 5 articles on an average week.
  • Search Interest

    21 people have searched for OMER on MarketBeat in the last 30 days. This is an increase of 2,000% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Omeros to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Omeros insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.90% of the stock of Omeros is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    48.79% of the stock of Omeros is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Omeros' insider trading history.
Receive OMER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omeros and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OMER Stock News Headlines

HC Wainwright Has Positive Outlook of Omeros FY2025 Earnings
Gold surges past $3,600 … but this has beat gold by 1,000x
Gold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real opportunity isn’t in coins or bullion. In every major gold rally of the past 50 years, there’s been another investment that has delivered dramatically higher returns.tc pixel
Omeros' (OMER) Buy Rating Reiterated at D. Boral Capital
Omeros (NASDAQ:OMER) Price Target Raised to $20.00
Omeros' (OMER) "Strong-Buy" Rating Reiterated at WBB Securities
See More Headlines

OMER Stock Analysis - Frequently Asked Questions

Omeros' stock was trading at $9.88 at the beginning of the year. Since then, OMER shares have decreased by 18.0% and is now trading at $8.10.

Omeros Corporation (NASDAQ:OMER) released its earnings results on Thursday, August, 14th. The biopharmaceutical company reported ($0.53) earnings per share for the quarter, topping the consensus estimate of ($0.55) by $0.02. The biopharmaceutical company earned $28.60 million during the quarter, compared to the consensus estimate of $0.31 million.
Read the conference call transcript
.

The following companies are subsidiaries of Omeros: Nura.

Top institutional investors of Omeros include Voya Investment Management LLC (0.02%). Insiders that own company stock include Peter A Md Demopulos, Gregory A Md Demopulos and Arnold C Hanish.
View institutional ownership trends
.

Shares of OMER stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Omeros investors own include JPMorgan Chase & Co. (JPM), Visa (V), AbbVie (ABBV), Meta Platforms (META), NVIDIA (NVDA), QUALCOMM (QCOM) and Global X Nasdaq 100 Covered Call ETF (QYLD).

Company Calendar

Last Earnings
8/14/2025
Today
10/20/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:OMER
CIK
1285819
Employees
210
Year Founded
1994

Price Target and Rating

High Price Target
$45.00
Low Price Target
$9.00
Potential Upside/Downside
+239.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$156.82 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-55.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.81
Quick Ratio
0.81

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.15) per share
Price / Book
-2.57

Miscellaneous

Outstanding Shares
68,060,000
Free Float
59,277,000
Market Cap
$551.29 million
Optionable
Optionable
Beta
2.32

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:OMER) was last updated on 10/20/2025 by MarketBeat.com Staff
From Our Partners